Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization

TARRYTOWN, N.Y., Nov. 21, 2020 /PRNewswire/ -- First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2 Authorized for recently diagnosed, mild to moderate COVID-19 in high-risk patients Initial doses of REGEN-COV2...

from PR Newswire: https://ift.tt/3fkt1CO